Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
7/24/2012 11:48:19 AM
More...
|
Ferring Pharmaceuticals, Inc. Acquires Licensing Rights for Elobixibat from Albireo
7/3/2012 9:38:07 AM
More...
|
Ajinomoto Pharmaceuticals and Albireo Announce Japan and Asia License Agreement for Elobixibat
4/3/2012 10:05:44 AM
More...
|
Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
10/12/2010 7:40:26 AM
More...
|
Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation
4/29/2010 10:22:57 AM
More...
|
Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
11/18/2009 11:57:06 AM
More...
|